The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams
The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt
Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
The plan is to advance innovative therapies to drug-resistant cancers
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Upon closing, the Quakertown business will become an independent company called Microsize
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Subscribe To Our Newsletter & Stay Updated
